How do hospital characteristics and ties relate to the uptake of second-generation biosimilars? A longitudinal analysis of Portuguese NHS hospitals, 2015

How do hospital characteristics and ties relate to the uptake of second-generation biosimilars? A longitudinal analysis of Portuguese NHS hospitals, 2015–2021

Published:2022-11-17 Issue:1 Volume:23 Page:99-109
ISSN:1473-7167
Container-title:Expert Review of Pharmacoeconomics & Outcomes Research
language:en
Short-container-title:Expert Review of Pharmacoeconomics & Outcomes Research

Author:

Perelman Julian¹²^ORCID,Duarte-Ramos Filipa³⁴^ORCID,Melo Gouveia António⁵,Pinheiro Luis⁶,Ramos Francisco¹,Vogler Sabine⁷^ORCID,Mateus Céu⁸^ORCID

Affiliation:

1. NOVA National School of Public Health, Comprehensive Health Research Center, CHRC, NOVA University of Lisbon, Lisbon, Portugal

2. Comprehensive Health Research Center, Nova University of Lisbon, Portugal

3. EPIUnit - Instituto de Saúde Pública, Universidade do Porto, Porto, Portugal

4. Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Portugal

5. Instituto Português de Oncologia de Lisboa, Portugal

6. Centro Hospitalar Universitário de Lisboa Norte, Portugal

7. WHO Collaborating Centre for Pharmaceutical Pricing and Reimbursement Policies, Pharmacoeconomics Department, Austrian National Public Health Institute (Gesundheit Österreich GmbH/GÖG), Austria

8. Health Economics at Lancaster, Division of Health Research, Lancaster University, Lancaster, UK

Funder

funding

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Health Policy,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14737167.2023.2146579

Reference36 articles.

1. The High Cost of Prescription Drugs in the United States

2. The high price of anticancer drugs: origins, implications, barriers, solutions

3. Trends in Prescription Drug Launch Prices, 2008-2021

4. Medicines with one seller and many buyers: strategies to increase the power of the payer

5. Pharmaceutical Expenditure And Policies

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Charting the Etanercept Journey: Tracing Cost Dynamics in Poland’s Off-Patent Market from Reference Drug Rivalry to Biosimilar Monopoly;BioDrugs;2024-06-11

2. Policy measures and instruments used in European countries to increase biosimilar uptake: a systematic review;Frontiers in Public Health;2024-02-28

3. Interface policies bridging outpatient and hospital sectors in Europe: can cross-sectorial collaboration in reimbursement and procurement improve access to affordable medicines?;Expert Review of Pharmacoeconomics & Outcomes Research;2023-07-26